Preliminary lab studies show two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses are able to neutralize it, and pictured, Dr. Manjul Shukla transfers Pfizer COVID-19 vaccine into a syringe, on Dec. 2, in Worcester, Massachusetts. (Steven Senne/AP)